Profil
John Womelsdorf worked as Vice President-Business Development at Optimer Pharmaceuticals LLC and Cyclacel Pharmaceuticals, Inc. He holds an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree, and a doctorate from Stevens Institute of Technology.
Anciens postes connus de John Womelsdorf
| Sociétés | Poste | Fin |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 17/04/2009 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | - |
Formation de John Womelsdorf
| Stevens Institute of Technology | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |